What is a minimally important difference (MID)? Does it have a role for EQ-5D instruments?
Despite ongoing concerns about the use of the minimally important difference (MID) – particularly in relation to EQ-5D index scores – the concept remains widely adopted in research and practice. In this webinar, Nan Luo (National University of Singapore) will provide an overview of MIDs and offer insights into current perspectives on their use; Nick…
Read MoreDevelopment of the EQ-DAPHNIE Data Collection Infrastructure
What is the EQ-DAPHNIE infrastructure? How has it maximized data quality? Learn all about the robust data collection resource in our upcoming webinar. Discussions will be led by Jeff Johnson (Dean and Professor of School of Public Health, University of Alberta) and Juan M. Ramos-Goñi (Principal and co-founder of Maths in Health).
Read MoreEQ-5D-Y-5L psychometric properties and value preferences on health gains for children and adolescents
Jiabi Wen (University of Alberta) will share what she has learned about psychometric properties of the EQ-5D-Y-5L in children with juvenile idiopathic arthritis. Ashwini De Silva (The University of Melbourne) will present her work on understanding people’s views on the relative value of health gains for children, adolescents and young adults compared to adults. After…
Read MoreMapping EQ-5D-5L in dementia and translating EQ-5D-3L into Krio
Hannah Hussain (University of Sheffield) will present her research on mapping a combined EQ-5D-5L utility score in dementia patients by integrating self- and proxy-reports. Daniel Youkee (King’s College London) will share what he has learned when applying an equivalence framework to translate the EQ-5D-3L into Krio in Sierra Leone. After their brief presentations, they will…
Read MoreEQ-5D (-Y) Valuation from adult and child perspectives.
Valuation from adult and child perspectives. Where does the empirical evidence leave us and how should we proceed? Economic evaluations for pediatric interventions necessitate, measurement and valuation of children and adolescents’ health. EuroQol has developed the EQ-5D-Y (3L & 5L) instruments specifically for this population and the first value sets have been published. A key…
Read MoreMeasuring Carer Outcomes using the EQ-5D
This Core Knowledge Panel starts with an introduction to carer outcomes and its measurement by Lidia Engel (Monash University). After this overview, Jan Faller (Monash University) will present a review of EQ-5D validation studies in informal carers as well as their own psychometric findings. Valeriia Sokolova (Monash University) will present psychometric evidence collected from informal carers of persons living with dementia.…
Read MoreMeasurement, Bolt-ons, and Translations
This Core Knowledge Panel (90 min) starts with an introduction to measurement by Brendan Mulhern (University of Technology Sydney), who chairs the Descriptive System Working Group. After this overview, Fanni Rencz (Corvinus University of Budapest) will introduce the concept of bolt-ons (items that supplement the EQ-5D-5L) and Michael Herdman (National University of Singapore) will introduce the translation process. Yifan Ding (Erasmus MC), Aiping Chua (National…
Read MoreAn introduction to causal inference and directed acyclic graphs (DAGs): why should I care?
Speaker: Dr. Peter Tennant, Associate Professor of Health Data Science, University of Leeds, England
Read MoreImproving measurement of children’s HRQoL: results from the QUOKKA project
Speaker: Nancy Devlin, Professor Health Economics, The University of Melbourne Australia, Board Chair EuroQol Research FoundationSpeaker: Kim Dalziel, Professor Health Economics, The University of Melbourne, AustraliaSpeaker: Christine Mpundu-Kaambwa, Research Fellow Health Economics, Flinders University, Australia
Read MoreRecall period and health fluctuations in health-related quality of life measurement
Moderator/Speaker: Dr Tessa Peasgood, Senior Lecturer in Health Economics, University of Sheffield, UK Speaker: Dr Sabina Sanghera, Senior Lecturer in Health Economics, University of Bristol, UKSpeaker: Dr Bernhard Michalowsky, Health Economist, German Center for Neurodegenerative Diseases, GermanySpeaker: Dr Ai Ping Chua, Senior Consultant, Division of Respiratory Medicine, Department of Medicine, Ng Teng Fong General Hospital, Singapore
Read More